Hydrocortisone Iodoquinol HYDROCORTISONE AND IODOQUINOL WESTMINSTER PHARMACEUTICALS, LLC FDA Approved Each gram contains 10 mg of hydrocortisone and 10 mg of iodoquinol in a vehicle consisting of: cetyl alcohol, glycerin, glyceryl stearate SE, mineral oil, PEG-100 stearate, phenoxyethanol, purified water, stearyl alcohol, white petrolatum, xanthan gum. Paraben Free. Chemically, hydrocortisone is [Pregn-4-ene-3, 20-dione, 11, 17, 21-trihydroxy-, (11β)-] with the molecular formula C 21 H 30 O 5 ) and is represented by the following structural formula: and iodoquinol, 5, 7-diiodo-8-quinolinol (C 9 H 5 I 2 NO) is represented by the following structural formula: Hydrocortisone is an anti-inflammatory and antipruritic agent, while iodoquinol is an antifungal and antibacterial agent. Chemical Structure Chemical Structure
FunFoxMeds box
Substance Hydrocortisone
Route
TOPICAL
Package NDC

Drug Facts

Composition & Profile

Treats Conditions
Indications Based On A Review Of A Related Drug By The National Research Council And Subsequent Fda Classification For That Drug The Indications Are As Follows Possibly Effective Contact Or Atopic Dermatitis Impetiginized Eczema Nummular Eczema Endogenous Chronic Infectious Dermatitis Stasis Dermatitis Pyoderma Nuchal Eczema And Chronic Eczematoid Otitis Externa Acne Urticata Localized Or Disseminated Neurodermatitis Lichen Simplex Chronicus Anogenital Pruritus Vulvae Scroti Ani Folliculitis Bacterial Dermatoses Mycotic Dermatoses Such As Tinea Capitis Cruris Corporis Pedis Moniliasis Intertrigo Final Classification Of The Less Than Effective Indications Requires Further Investigation
Pill Appearance
Color: yellow

Identifiers & Packaging

Container Type BOX
All Product Codes
UNII
WI4X0X7BPJ 63W7IE88K8
Packaging

HOW SUPPLIED 1 oz. tubes, NDC 69367-286-01 To report a serious adverse event or obtain product information, call 1-844-221-7294.; PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton NDC 69367-286-01 Rx Only Hydrocortisone 1%-Iodoquinol 1% Cream Westminster Pharmaceuticals Net Wt 1 oz (28.4 g) PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton

Package Descriptions
  • HOW SUPPLIED 1 oz. tubes, NDC 69367-286-01 To report a serious adverse event or obtain product information, call 1-844-221-7294.
  • PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton NDC 69367-286-01 Rx Only Hydrocortisone 1%-Iodoquinol 1% Cream Westminster Pharmaceuticals Net Wt 1 oz (28.4 g) PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton

Overview

Each gram contains 10 mg of hydrocortisone and 10 mg of iodoquinol in a vehicle consisting of: cetyl alcohol, glycerin, glyceryl stearate SE, mineral oil, PEG-100 stearate, phenoxyethanol, purified water, stearyl alcohol, white petrolatum, xanthan gum. Paraben Free. Chemically, hydrocortisone is [Pregn-4-ene-3, 20-dione, 11, 17, 21-trihydroxy-, (11β)-] with the molecular formula C 21 H 30 O 5 ) and is represented by the following structural formula: and iodoquinol, 5, 7-diiodo-8-quinolinol (C 9 H 5 I 2 NO) is represented by the following structural formula: Hydrocortisone is an anti-inflammatory and antipruritic agent, while iodoquinol is an antifungal and antibacterial agent. Chemical Structure Chemical Structure

Indications & Usage

INDICATIONS Based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug, the indications are as follows: "Possibly" Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo. Final classification of the less-than-effective indications requires further investigation.

Dosage & Administration

Apply to affected area 3 to 4 times daily in accordance with physician's directions.

Warnings & Precautions
WARNING FOR EXTERNAL USE ONLY.
Contraindications

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria.

Storage & Handling

STORAGE Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. Keep container tightly closed. NOTICE Protect from freezing and excessive heat.


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →